ArticleCancer research and treatment2020

RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast Cancer.

Tian-Hao Weng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.